Navigation Links
ForteBio Discusses How to Achieve Higher Throughput With Multiplexed Phage Display in Educational Webinar
Date:9/15/2018

Recent advances in phage display for molecular evolution incorporate deep sequencing to enable greater library coverage. However, severe gaps and limitations associated with next-generation sequencing (NGS) library construction and biophysical follow-up of potential hits remain.

Multiplexed phage display provides a simple, robust, and seamless high-throughput-ready version of phage display that can simultaneously screen and bioinformatically analyze up to 96 peptide phage libraries in parallel.

As a case study, raising peptide binders against the low-density lipoprotein receptor-related protein 6 (LRP6) using MPD generated more detailed results in a shorter time than standard phage display methods. To accommodate the large number of potential lead peptides from the screening, the ForteBio Octet system was used to characterize streptavidin peptide fusions generated by in vitro translation.

In this webinar, which is sponsored by ForteBio LLC, attendees will learn to use next-generation sequencing for phage display. They will also understand how to generate streptavidin peptide fusions quickly and inexpensively.

The speaker for this event will be Dr. Thomas Hengstl, a software product manager with Molecular Devices.

Hengstl is currently a product manager for software and compliance with Molecular Devices. Prior to joining the company, he received his doctorate in biophysics and biochemistry through a joint international, industrial program between the University of Natural Sciences Salzburg and Genentech Inc. The development of the multiplexed phage display workflow described in the webinar was a product of his doctorate program.

LabRoot will host the webinar September 27, 2018, beginning at 8 a.m. PDT. To learn more about this event, discover the continuing education credits available, or to register for free, click here.

About Pall ForteBio
Pall ForteBio is a division of Pall Life Sciences that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems facilitate real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. Pall ForteBio's analytical solutions enable more efficient and accurate characterization of drug candidates, delivering greater value to the drug discovery and development markets.

For more information, visit http://www.fortebio.com.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at https://www.prweb.com/releases/fortebio_discusses_how_to_achieve_higher_throughput_with_multiplexed_phage_display_in_educational_webinar/prweb15763879.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. PA Physician General Discusses Opioid Crisis at American Academy of Pain Medicines Annual Convention
2. nThrive Discusses Improving Patient Satisfaction and Increasing Cash Flow Velocity at HIMSS 2017
3. Pressure BioSciences, Inc. Discusses Research Market, Goals and Milestones for First Half of 2017 in New SNNLive Video Interview with StockNewsNow.com
4. Ampronix Discusses Sonys New Medical Innovations for 2017
5. Anesthesia Business Consultants Discusses Medical Marijuana in Anesthesia and Chronic Pain Practice
6. Onconova Therapeutics, Inc. Discusses Target Indications and Clinical Development in New SNNLive Video Interview on StockNewsNow.com
7. RXi Pharmaceuticals Corporation Discusses Competitive Advantage, Goals and Milestones for 2016-2017 in New SNNLive Newscast on StockNewsNow.com
8. Medical Diagnostic Imaging Company Ampronix Discusses Technology Advancements Within Radiology and Healthcare Sector - Risks Still Present to Patients
9. Regen BioPharma, Inc. Discusses Recent Developments in Aplastic Anemia Therapy and Future Potential Expansion of HemaXellerate
10. RI Physical Therapist Discusses Alternatives to Rising Opioid Use
11. Founder Paul West Discusses AFMWorkshops Contribution to Democratization of Technology in "American Laboratory" Feature Story on Atomic Force Microscopy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2019)... SAN ANTONIO (PRWEB) , ... June 12, 2019 , ... ... year. For many patients undergoing breast cancer surgery, breast reconstruction plays ... rise, the number of overweight patients seeking breast reconstruction is also increasing. There ...
(Date:6/11/2019)... ... June 11, 2019 , ... The National ... NCCN Chemotherapy Order Templates ( NCCN Templates ®) into the CureMD Oncology EHR ... the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). , “The collaboration with ...
(Date:6/11/2019)... ... June 11, 2019 , ... MabPlex International Ltd ... serving the global biopharmaceutical and biotechnology industries with sites in China and the ... new Chief Executive Officer (CEO). Dr Chen will be responsible for the company's ...
Breaking Medicine Technology:
(Date:6/13/2019)... , ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs ... , Painful periods , Heavy bleeding , Irregular menstruation ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with ...
(Date:6/13/2019)... ... ... Obstetrics and Gynecology specializes in pelvic pain treatment for women. Pelvic pain can occur ... handles routine and complicated pelvic pain conditions including:, , Uterine fibroids ... Adhesions (scar tissue) , Interstitial Cystitis , Pelvic ...
(Date:6/13/2019)... ... , ... In Partnership with the Smiles for Everyone Foundation , ... Mesquite, TX office on July 13th. , Dental services provided include same-day procedures such ... For more information, please visit the Monarch Dental website . , About Monarch ...
(Date:6/13/2019)... ... ... Hard money lenders like Monroe Funding Corporation are able to respond and approve ... If the documentation and collateral are immediately available, it’s possible to receive approval and ... with a traditional lender, which allows loans to be customized and adjusted based on ...
(Date:6/13/2019)... CHICAGO (PRWEB) , ... June 13, 2019 , ... In ... in schools across the United States, the collective impact movement Active Schools ... or are not, promoting childhood health and well-being. , The U.S. Department of ...
Breaking Medicine News(10 mins):